BRCA1 and breast carcinoma: Many works have demonstrated the correlation between each of the approximately 300 BRCA1/2 mutations identified so far and HRD-mutated breast cancer onset, especially for the TNBC subtype [62,63], making it clear that at least BRCA1/2 germline assessment should be performed in people with a family history of breast cancer.